Microglia and Alzheimer's disease pathogenesis

Cited by (336)

Items 101–200 of 336

1. Human CNS immune senescence and neurodegeneration
   Streit, Wolfgang J, Xue, Qing-Shan · 2014 · Current Opinion in Immunology
2. New Challenges of HIV-1 Infection: How HIV-1 Attacks and Resides in the Central Nervous System
   Victoria Rojas-Celis, Fernando Valiente‐Echeverría, Ricardo Soto‐Rifo, Daniela Toro‐Ascuy · 2019 · Cells
3. The interplay between inflammation and neurodegeneration in CNS disease
   Margaret M. Esiri · 2006 · Journal of Neuroimmunology
4. Effect of aging on the microglial response to peripheral nerve injury
   Conde, Jessica R., Streit, Wolfgang J. · 2006 · Neurobiology of Aging
5. The role of glycogen synthase kinase 3 in the early stages of Alzheimers’ disease
   Félix Hernández, Jesús Ávila · 2008 · FEBS Letters
6. Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology
   Jayasri Das Sarma · 2013 · Journal of NeuroVirology
7. The Role of Microglia in Sporadic Alzheimer’s Disease
   Wolfgang J. Streit, Habibeh Khoshbouei, Ingo Bechmann · 2021 · Journal of Alzheimer s Disease
8. Glia and Methylmercury Neurotoxicity
   Mingwei Ni, Xin Li, João Batista Teixeira da Rocha, Marcelo Farina, Michael Aschner · 2012 · Journal of Toxicology and Environmental Health
9. Common schizophrenia risk variants are enriched in open chromatin regions of human glutamatergic neurons
   Mads E. Hauberg, Jordi Creus‐Muncunill, Jaroslav M. Bendl, Alexey Kozlenkov, Biao Zeng, Chuhyon Corwin, Sarah Chowdhury, Harald D. Kranz, Yasmin L. Hurd, Michael Wegner et al. · 2020 · Nature Communications
10. Role of Fractalkine/CX3CR1 Interaction in Light-Induced Photoreceptor Degeneration through Regulating Retinal Microglial Activation and Migration
    Meng Zhang, Gezhi Xu, Wei Da Liu, Yingqin Ni, Wenting Zhou · 2012 · PLoS ONE
11. The role of regulatory T cells in neurodegenerative diseases
    Feng Q. HeFeng, Rudi Balling · 2012 · WIREs Systems Biology and Medicine
12. Microglia as a critical player in both developmental and late-life CNS pathologies
    Derecki, Noël C., Katzmarski, Natalie, Kipnis, Jonathan, Meyer-Luehmann, Melanie · 2014 · Acta Neuropathologica
13. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease
    Tim Karl, Brett Garner, David Cheng · 2016 · Behavioural Pharmacology
14. Microglial cells in neurodegenerative disorders.
    Marcin Wojtera, Beata Sikorska, Tomasz Sobów, Pawel Piotr Liberski · 2005 · PubMed
15. Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers
    Oleg Butovsky, Shay Bukshpan, Gilad Kunis, Steffen Jung, Michal Schwartz · 2007 · Molecular and Cellular Neuroscience
16. The Brain's Aging Immune System.
    Wolfgang J. Streit, Qing‐Shan Xue · 2010 · PubMed Central
17. CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
    Jeremy L. Koppel, Valérie Vingtdeux, Philippe Marambaud, Cristina d’Abramo, Heidy T. Jimenez, Mark Stauber, Rachel Friedman, Peter Davies · 2013 · Molecular Medicine
18. Chlorpyrifos pesticide promotes oxidative stress and increases inflammatory states in BV-2 microglial cells: A role in neuroinflammation
    Grazielle Castagna Cezimbra Weis, Charles Elias Assmann, Vitor Bastianello Mostardeiro, Audrei de Oliveira Alves, Jéssica Righi da Rosa, Micheli Mainardi Pillat, Cínthia Melazzo de Andrade, Maria Rosa Chitolina Schetinger, Vera Maria Morsch, Ivana Beatrice Mânica da Cruz et al. · 2021 · Chemosphere
19. Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage
    David Morgan Thomas, Dina M. Francescutti, Donald M. Kuhn · 2005 · The FASEB Journal
20. Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
    Violetta Refolo, Nadia Stefanova · 2019 · Frontiers in Cellular Neuroscience
21. In vivo evidence for microglial activation in neurodegenerative dementia
    Annachiara Cagnin, Michael Kassiou, Steven R. Meikle, Richard B. Banati · 2006 · Acta Neurologica Scandinavica
22. Riluzole reduces amyloid beta pathology, improves memory, and restores gene expression changes in a transgenic mouse model of early-onset Alzheimer’s disease
    Masahiro Okamoto, Jason D. Gray, Chloe S. Larson, Syed Faraz Kazim, Hideaki Soya, Bruce S. McEwen, Ana C. Pereira · 2018 · Translational Psychiatry
23. Differential Regulation of Adhesion and Phagocytosis of Resting and Activated Microglia by Dopamine
    Fan Yang, Zhilu Chen, Janak Lal. Pathak, Ana M.D. Carneiro, Chang Y. Chung · 2018 · Frontiers in Cellular Neuroscience
24. Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
    Chanchal Sharma, Hanwoong Woo, Sang Ryong Kim · 2022 · Biomedicines
25. Neuroprotective Mechanisms of Ginsenoside Rb1 in Central Nervous System Diseases
    Liang Gong, Jiayi Yin, Yu Zhang, Huang Ren, Yuxuan Lou, Haojie Jiang, Liyan Sun, Jing Jia, Xiansi Zeng · 2022 · Frontiers in Pharmacology
26. Microglial response to experimental periodontitis in a murine model of Alzheimer’s disease
    Alpdoğan Kantarcı, Christina M. Tognoni, Wael Yaghmoor, Amin A. Marghalani, Danielle N. Stephens, Jae-Yong Ahn, Isabel Carreras, Alpaslan Dedeoglu · 2020 · Scientific Reports
27. Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
    Qinyuan Xu, Pierre Boerkoel, Veronica Hirsch‐Reinshagen, Ian R. Mackenzie, Ging‐Yuek Robin Hsiung, Geoffrey Charm, Elliott To, Alice Liu, Katerina D. Schwab, Kailun Jiang et al. · 2022 · Acta Neuropathologica Communications
28. Neuroprotective Effects of Naloxone against Light-Induced Photoreceptor Degeneration through Inhibiting Retinal Microglial Activation
    Yingqin Ni, Gezhi Xu, Wenzheng Hu, Le Shi, Yaowu Qin, Cuidi Da · 2008 · Investigative Ophthalmology & Visual Science
29. Regulation of Neuroinflammation by Herbal Medicine and Its Implications for Neurodegenerative Diseases
    Kyoungho Suk · 2005 · Neurosignals
30. Different Neurotropic Pathogens Elicit Neurotoxic CCR9- or Neurosupportive CXCR3-Expressing Microglia
    He Li, Zhou Gang, Yuling He, Xie Luokun, Xiong Jie, Hao Chuan Lei, Wei Li, Hu Chunsong, Liu Junyan, Jiang Mingshen et al. · 2006 · The Journal of Immunology
31. Association between the Polymorphisms of TLR4 and CD14 Genes and Alzheimers Disease
    Carmela Rita Balistreri, M. Grimaldi, Martina Chiappelli, Federico Licastro, Laura Castiglia, Florinda Listı̀, Sonya Vasto, Domenico Lio, Calogero Caruso, Giuseppina Candore · 2008 · Current Pharmaceutical Design
32. Differential regulation of Abeta42-induced neuronal C1q synthesis and microglial activation.
    Rong Fan, Andrea J. Tenner · 2005 · Journal of Neuroinflammation
33. Metallothionein-I and -III expression in animal models of Alzheimer disease
    Javier Carrasco, Paul Anthony Adlard, Carl W. Cotman, Albert Quintana, Milena Penkowa, F. Xu, William E. Van Nostrand, Juan Hidalgo · 2006 · Neuroscience
34. Proteinase-Activated Receptor-2 Exerts Protective and Pathogenic Cell Type-Specific Effects in Alzheimer’s Disease
    Amir Afkhami-Goli, Farshid Noorbakhsh, Avril J. Keller, Nathalie Vergnolle, David A. Westaway, Jack H. Jhamandas, Patricia Andrade‐Gordon, Morley Donald Hollenberg, Hossein-Ali Arab, Richard H. Dyck et al. · 2007 · The Journal of Immunology
35. Gemfibrozil, a Lipid-Lowering Drug, Upregulates IL-1 Receptor Antagonist in Mouse Cortical Neurons: Implications for Neuronal Self-Defense
    Grant T. Corbett, Avik Roy, Kalipada Pahan · 2012 · The Journal of Immunology
36. Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?
    Melanie Meyer‐Luehmann, Marco Prinz · 2015 · Trends in Neurosciences
37. Neuroinflammation and Parkinson's disease.
    S. Przedborski · 2007 · Handbook of Clinical Neurology
38. Cobalamin deficiency, hyperhomocysteinemia, and dementia
    Werder · 2010 · Neuropsychiatric Disease and Treatment
39. γ‐Secretase component presenilin is important for microglia β‐amyloid clearance
    Dorit Farfara, Dorit Trudler, Niva Segev‐Amzaleg, Ronit Galron, Reuven Stein, Dan Frenkel · 2010 · Annals of Neurology
40. GSK3β is involved in promoting Alzheimer’s disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F/NL-F knock-in mice
    Muzhou Jiang, Xinwen Zhang, Xu Yan, Shinsuke Mizutani, Haruhiko Kashiwazaki, Junjun Ni, Zhou Wu · 2021 · Brain Behavior and Immunity
41. Intracellular calcium signalling in Alzheimer’s disease
    Marina Hermes, Gerhard Eichhoff, Olga Garaschuk · 2009 · Journal of Cellular and Molecular Medicine
42. Evolution of Siglec-11 and Siglec-16 Genes in Hominins
    Xiaoxia Wang, N. K. Mitra, Pedro Cruz, Liwen Deng, NISC Comparative Sequencing Program, Nissi M. Varki, Takashi Angata, Eric D. Green, James C. Mullikin, Toshiyuki Hayakawa et al. · 2012 · Molecular Biology and Evolution
43. Expression of Metallothionein-I, -II, and -III in Alzheimer Disease and Animal Models of Neuroinflammation
    Juan Hidalgo, Milena Penkowa, Carmen Espejo, Eva María Martínez-Cáceres, Javier Carrasco, Albert Quintana, Amalia Molinero, Sergi Florit, Mercedes Giralt, Arantxa Ortega Aznar · 2006 · Experimental Biology and Medicine
44. Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases
    Anshuman Singh, Shubham Upadhayay, Sidharth Mehan · 2021 · Neurotoxicity Research
45. High field 1H MRS of the hippocampus after donepezil treatment in Alzheimer disease
    Robert Bartha, Matthew Smith, Raul Rupsingh, Rebecca Jane Rylett, Jennie Wells, MICHAEL J. BORRIE · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
46. Valproic acid enhances microglial phagocytosis of amyloid-β1–42
    A.M. Smith, Hannah M. Gibbons, Mike Dragunow · 2010 · Neuroscience
47. Effects of acoustic trauma on the auditory system of the rat: The role of microglia
    Joan Susan Baizer, Keit Men Wong, Senthilvelan Manohar, Sarah H. Hayes, Dalian Ding, R. Dingman, Richard Salvi · 2015 · Neuroscience
48. Minocycline Alleviates Sevoflurane-Induced Cognitive Impairment in Aged Rats
    Yue Tian, Shanbin Guo, Xiuying Wu, Ling Ma, Xiaochun Zhao · 2015 · Cellular and Molecular Neurobiology
49. DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations
    Susan F. Crocker, Willard J. Costain, H.A. Robertson · 2006 · Brain Research
50. Microglia in Neurodegenerative Disorders
    Darío Tejera, Michael Thomas Heneka · 2019 · Methods in molecular biology
51. Age‐Related Inflammatory Diseases
    Giuseppina Candore, Carmela Rita Balistreri, Maria Paola Grimaldi, Sonya Vasto, Florinda Listı̀, Martina Chiappelli, Federico Licastro, Domenico Lio, Calogero Caruso · 2006 · Annals of the New York Academy of Sciences
52. HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins
    Sushama Jadhav, V. Nema · 2021 · Mediators of Inflammation
53. The flavonoid rutin modulates microglial/macrophage activation to a CD150/CD206 M2 phenotype
    Alessandra Bispo da Silva, Paulo Lucas Cerqueira Coelho, Jéssika Alves Oliveira Amparo, Monique Marylin Alves de Almeida, Julita Maria Pereira Borges, Cleide Dos Santos Souza, Maria de Fátima Dias Costa, Míriam Mecha, Carmen Guaza Rodriguez, Víctor Diógenes Amaral da Silva et al. · 2017 · Chemico-Biological Interactions
54. Alzheimer’s disease: Channeling APP to non-amyloidogenic processing
    Bor Luen Tang · 2005 · Biochemical and Biophysical Research Communications
55. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells
    Takato Takenouchi, Mitsuru Sato, Hiroshi Kitani · 2007 · Journal of Neurochemistry
56. The therapeutic potential of the endocannabinoid system for Alzheimer's disease
    Tim Karl, David Cheng, Brett Garner, Jonathon Carl Arnold · 2012 · Expert Opinion on Therapeutic Targets
57. Clinical and Immunopathologic Alterations in Rhesus Macaques Affected with Globoid Cell Leukodystrophy
    Juan T. Borda, Xavier A. Alvarez, Mahesh Mohan, Marion S. Ratterree, Kathrine M. Phillippi‐Falkenstein, Andrew A. Lackner, Bruce Alan Bunnell · 2007 · American Journal Of Pathology
58. Microglial Senescence and Activation in Healthy Aging and Alzheimer’s Disease: Systematic Review and Neuropathological Scoring
    Antonio Malvaso, Alberto Gatti, Giulia Negro, Chiara Calatozzolo, Valentina Medici, Tino Emanuele Poloni · 2023 · Cells
59. Towards Alzheimer's root cause: ECSIT as an integrating hub between oxidative stress, inflammation and mitochondrial dysfunction
    Montserrat Soler‐López, Nahuai Badiola, Andreas Zanzoni, Patrick Aloy · 2012 · BioEssays
60. Self-Esteem and Autonomic Physiology: Parallels Between Self-Esteem and Cardiac Vagal Tone as Buffers of Threat
    Andy Martens, Jeff Greenberg, John J. B. Allen · 2008 · Personality and Social Psychology Review
61. Emerging potential of cannabidiol in reversing proteinopathies
    Raju Dash, Md. Chayan Ali, Israt Jahan, Yeasmin Akter Munni, Sarmistha Mitra, Md. Abdul Hannan, Binod Timalsina, Diyah Fatimah Oktaviani, Ho Jin Choi, Il Soo Moon · 2020 · Ageing Research Reviews
62. Neurotensin and the neurotensin receptor‐3 in microglial cells
    Stéphane Martin, Eleni Dicou, Jean‐Pierre Vincent, Jean Mazella · 2005 · Journal of Neuroscience Research
63. A Derivative of the Brain Metabolite Lanthionine Ketimine Improves Cognition and Diminishes Pathology in the 3×Tg-AD Mouse Model of Alzheimer Disease
    Kenneth Hensley, S. Prasad Gabbita, Kalina M. Venkova, Alexandar M. Hristov, Ming F. Johnson, Pirooz Eslami, Marni E. Harris‐White · 2013 · Journal of Neuropathology & Experimental Neurology
64. Inhibition of mitochondrial fission attenuates Aβ-induced microglia apoptosis
    Nanchang Xie, Chunru Wang, Yajun Lian, Chuanjie Wu, H Zhang, Quanling Zhang · 2013 · Neuroscience
65. Chronic brain inflammation causes a reduction in GluN2A and GluN2B subunits of NMDA receptors and an increase in the phosphorylation of mitogen-activated protein kinases in the hippocampus
    Jinhua Ma, Bo‐Ryoung Choi, ChiHye Chung, Sun Seek Min, Won Kyung Jeon, Jung‐Soo Han · 2014 · Molecular Brain
66. Microglia Cell Culture: A Primer for the Novice
    Anke Witting, Thomas Möller · 2011 · Methods in molecular biology
67. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer’s disease
    Collins, Jessica M., King, Anna E., Woodhouse, Adele, Kirkcaldie, Matthew T.K., Vickers, James C. · 2015 · Experimental Neurology
68. Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664
    Verónica Galván, Junli Zhang, Olivia F. Gorostiza, Surita Banwait, Wei Huang, Marina Ataie, Huidong Tang, Dale E. Bredesen · 2008 · Behavioural Brain Research
69. Methamphetamine‐induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling
    David Morgan Thomas, Dina M. Francescutti, Donald M. Kuhn · 2008 · Journal of Neurochemistry
70. Untitled work
    2012 · PubMed
71. TLR4-mediated brain inflammation halts neurogenesis: impact of hormonal replacement therapy
    Abdeslam Mouihate · 2014 · Frontiers in Cellular Neuroscience
72. Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
    Roland Jakob‐Roetne, Helmut Jacobsen · 2009 · Angewandte Chemie
73. Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid
    Sudipta Chakrabarti, Malabendu Jana, Avik Roy, Kalipada Pahan · 2018 · Current Alzheimer Research
74. Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats
    Harikesh Kalonia, Puneet Kumar, Anil Kumar · 2010 · Brain Research
75. Vaccination with a non-human random sequence amyloid oligomer mimic results in improved cognitive function and reduced plaque deposition and micro hemorrhage in Tg2576 mice
    Suhail Rasool, Ricardo Albay, Hilda Martínez‐Coria, Leonid Breydo, Jessica Wu, Saskia C. F. Milton, Sunit Misra, Andy T Tran, Anna Pensalfini, Frank M. LaFerla et al. · 2012 · Molecular Neurodegeneration
76. Sequence Variants of Toll Like Receptor 4 and Late-Onset Alzheimer's Disease
    Chen, Yen-Ching, Yip, Ping-Keung, Huang, Yi-Ling, Sun, Yu, Wen, Li-Li, Chu, Yi-Min, Chen, Ta-Fu · 2012 · PLoS ONE
77. Neuroprotective effect of 1-Deoxynojirimycin on cognitive impairment, β-amyloid deposition, and neuroinflammation in the SAMP8 mice
    Weike Chen, Tingting Liang, Wen-Wen Zuo, Xin Wu, Zi-Bo Shen, Fang Wang, Cunyu Li, Yunfeng Zheng, Guoping Peng · 2018 · Biomedicine & Pharmacotherapy
78. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: A pharmacogenomic approach
    Giuseppina Candore, Carmela Rita Balistreri, Maria Paola Grimaldi, Florinda Listı̀, Sonya Vasto, Martina Chiappelli, Federico Licastro, Giuseppina Colonna‐Romano, Domenico Lio, Calogero Caruso · 2006 · Mechanisms of Ageing and Development
79. ERK1/2 and p38 MAP kinases control prion protein fragment 90–231‐induced astrocyte proliferation and microglia activation
    Stefano Thellung, Valentina Villa, Alessandro Corsaro, Francesca Pellistri, Valentina Venezia, Claudio Russo, Antonio Aceto, Mauro Robello, Tullio Florio · 2007 · Glia
80. Fibrillar β‐amyloid 1‐42 alters cytokine secretion, cholinergic signalling and neuronal differentiation
    Linn Malmsten, Swetha Vijayaraghavan, Outi Hovatta, Amelia Marutle, Taher Darreh‐Shori · 2014 · Journal of Cellular and Molecular Medicine
81. The central role of the NLRP3 inflammasome pathway in the pathogenesis of age-related diseases in the eye and the brain
    Jack Jonathan Maran, Moradeke M. Adesina, Colin Richard Green, Andrea Kwakowsky, Odunayo Omolola Mugisho · 2023 · Ageing Research Reviews
82. Induction of microglial apoptosis by corticotropin‐releasing hormone
    Jiyeon Ock, Heasuk Lee, Sangseop Kim, Won‐Ha Lee, Dong‐Kug Choi, Eun Jung Park, Sang‐Hyun Kim, In Kyeom Kim, Kyoungho Suk · 2006 · Journal of Neurochemistry
83. The effects of HIV and aging on subcortical shape alterations: A 3D morphometric study
    Taylor P. Kuhn, Daniel Schonfeld, Philip Sayegh, Alyssa Arentoft, Jacob D. Jones, Charles H. Hinkin, Susan Y. Bookheimer, April D. Thames · 2016 · Human Brain Mapping
84. Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease
    Wolfgang J. Streit, Leah T. Phan, Ingo Bechmann · 2024 · Pharmacological Reviews
85. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage
    Denise Ferrera, Nadia Mazzaro, Claudio Canale, Laura Gasparini · 2014 · Neurobiology of Aging
86. Nitric oxide mediated redox regulation of protein homeostasis
    Irmgard Tegeder · 2018 · Cellular Signalling
87. Microglia and Cholesterol Handling: Implications for Alzheimer’s Disease
    Oscar M. Muñoz Herrera, Angela M. Zivkovic · 2022 · Biomedicines
88. Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production
    Qing‐Shan Xue, D. Larry Sparks, Wolfgang J. Streit · 2007 · Journal of Neuroinflammation
89. Dopamine Disposition in the Presynaptic Process Regulates the Severity of Methamphetamine‐Induced Neurotoxicity
    Donald M. Kuhn, Dina M. Francescutti, David Morgan Thomas · 2008 · Annals of the New York Academy of Sciences
90. Microglial cell activation and senescence are characteristic of the pathology FXTAS
    Verónica Martínez‐Cerdeño, Tiffany Hong, Sarwat Amina, Mirna Lechpammer, Jeanelle Ariza, Flora Tassone, Stephen C. Noctor, Paul J. Hagerman, Randi Jenssen Hagerman · 2018 · Movement Disorders
91. Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease
    Deepthi Rapaka, Veera Raghavulu Bitra, Siva Reddy Challa, Paul Chukwuemeka Adiukwu · 2021 · Neuropeptides
92. Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
    Rommy von Bernhardi M. · 2010 · Journal of Alzheimer s Disease
93. Critical role of iron in the pathogenesis of the murine gangliosidoses
    Mylvaganam Jeyakumar, Ian Martin Williams, David A. B. Smith, Timothy Martin Cox, Frances M. Platt · 2009 · Neurobiology of Disease
94. Association between the Polymorphism of CCR5 and Alzheimer's Disease
    Carmela Rita Balistreri, Maria Paola Grimaldi, Sonya Vasto, Florinda Listı̀, Martina Chiappelli, Federico Licastro, Domenico Lio, Calogero Caruso, Giuseppina Candore · 2006 · Annals of the New York Academy of Sciences
95. CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease
    Jeremy L. Koppel, Valérie Vingtdeux, Philippe Marambaud, Cristina d’Abramo, Heidy T. Jimenez, Mark Stauber, Rachel Friedman, Peter Davies · 2013 · Molecular Medicine
96. Impact of the Cannabinoid System in Alzheimer's Disease
    Shuangtao Li, Yuan-Bing Huang, Lijun Yu, Xiao-yu Ji, Jie Wu · 2022 · Current Neuropharmacology
97. Chronic treadmill running protects hippocampal neurons from hypobaric hypoxia-induced apoptosis in rats
    C. Lin, C.-J. Wu, I‐Hua Wei, M.-H. Tsai, N.-W. Chang, Tingting Yang, Yu‐Min Kuo · 2012 · Neuroscience
98. Vitamin E increases S100B‐mediated microglial activation in an S100B‐overexpressing mouse model of pathological aging
    Lynn A. Bialowas‐McGoey, Agnieszka Lesicka, Patricia M. Whitaker‐Azmitia · 2008 · Glia
99. Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain
    Wolfgang J. Streit, Qing‐Shan Xue, Heiko Braak, Kelly Del Tredici · 2013 · Glia
100. TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis
     Han Zhang, Huaishan Wang, Fei Gao, Jia Ying Yang, Yi Xu, Yi Fu, Menghua Cai, Xue Zhang, Qi Yang, Kexin Tong et al. · 2021 · Neurobiology of Aging